Cargando…
Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
Guillain-Barré syndrome after Pfizer and Astra-Zeneca vaccinations against COVID-19 has been previously reported in the literature. The objective of this study was to report the first case of Guillain-Barré following the COVID-19 vaccination with the Johnson & Johnson COVID-19 vaccine. We report...
Autores principales: | Carranza, Octavio, Babici, Denis, Waheed, Sadia, Yousuf, Fawad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117845/ https://www.ncbi.nlm.nih.gov/pubmed/35602794 http://dx.doi.org/10.7759/cureus.24252 |
Ejemplares similares
-
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
por: Waheed, Sadia, et al.
Publicado: (2021) -
Guillain-Barré Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination
por: Ilyas, Usman, et al.
Publicado: (2022) -
VITT REACTION ASSOCIATED WITH JOHNSON & JOHNSON COVID-19 VACCINE
por: AKUNA, MELANIE, et al.
Publicado: (2021) -
Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021) -
Johnson and Johnson COVID-19 Vaccination Triggering Pheochromocytoma Multisystem Crisis
por: Haji, Nahel, et al.
Publicado: (2021)